论文部分内容阅读
对于新生儿硬肿症的研究.在世界上,我国可谓独占鳌头,目前正越来势深入到某些生化领域的研究中去,从而进一步指导治疗,取得更好的社会效益。上海和沈阳不约而同的对硬肿症时糖代谢进行了研究.东北发现在硬肿症时正常血糖者占86.3％,低血糖者占11.5％,并有2.1外患儿呈高血糖状态,华东发现硬肿症儿耐糖不良,硬肿越重.,耐糖越差,甚至在空腹时正呈高血糖状态,呈高血糖者预后差,基于以上结果,在治疗观点上有了发展,过
For the study of neonatal scleredecide, our country is the most famous in the world, and it is now getting more and more into the research of some biochemical fields, so as to further guide the treatment and achieve better social benefits. Shanghai and Shenyang invariably studied the metabolism of scleredema in northeast China found that normal blood glucose in patients with scleredema accounted for 86.3%, hypoglycemia accounted for 11.5%, and 2.1 outside the children were hyperglycemic state found in East China Scleroderma with poor resistance to sugar, the more severe sclerosis., The worse the sugar tolerance, even in the fasting state was hyperglycemia, hyperglycemia were poor prognosis, based on the above results, the treatment point of view has been the development of